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INTRODUCTION
Incidence of symptomatic urinary stones has been reported as 1/200-1/2500 (1) . Renal colic is the most frequent DOI: 10.4081/aiua.2014.2.86 non-obstructive cause of hospitalization during pregnancy with 80-90% of urinary stones in pregnant women diagnosed after the first trimester (2, 3) . Fifty to eighty per cent of pregnant patients with symptomatic stones tend to pass their stones spontaneously when treated conservatively with analgesics and hydration (1, 4) . Surgical intervention might be required in the presence of persistent obstruction or intractable pain refractory to analgesics which is the case in nearly one third of the patients (5) . Advances in fibre optic technology lead to the design of new ureteroscopes, which allow atraumatic access into upper urinary tract (6) and Holmium: YtriumAluminium-Garnet (YAG) laser lithotripsy demonstrated to be able to fragment all types of stone with a certain degree of safety (7) . These technical advances in laser lithotiptors and endoscopes offer the urologists an opportunity to safely treat urotlithiasis in pregnant women. In this study, we aimed to retrospectively analyze the effectiveness of the holmium: YAG laser lithotriptor with semi-rigid ureteroscope in the management of ureteral stones at different locations in pregnant women.
MATERIALS AND METHODS
In this study we retrospectively evaluated 19 pregnant women who presented to our clinics with the initial diagnosis of symptomatic hydronephrosis between January 2005 and December 2012. These patients whose renal colic and progressive hydronephrosis did not resolve despite conservative treatment during follow-up period underwent ureterorenoscopy (URS) for the detection and treatment of their stones. The medical files of these patients were retrospectively evaluated, and their ages, gestation trimesters, admission symptoms, diagnostic methods, degree of hydronephrosis, past history of urolithiasis or urological interventions, sizes and locations of stones and grades of complications based on modified Clavien criteria (8) were recorded. Diagnosis of ureteral obstruction was made based on actual clinical manifestations of the patients, their abdominal ultrasound (US) findings, and detection of haematuria in urinalysis. Obstructive stones were diagnosed in six (31.5%) patients by US. All patients were also evaluated with whole blood count, urea and creatinine measurements, urine and (if required) blood cultures. The patients underwent obstetric consultations in order to rule out obstetric complications and determine their gestational weeks. Conservative treatment such as intravenous fluid replacement and analgesics was started on all hospitalised patients. A third generation cephalosporin (ceftriaxone) was given in cases with infection. URS procedures were postponed in patients with active urinary system infection with documented bacterial growth in their urine cultures until their urine cultures became sterile. Preoperative anaesthesiologic and obstetric consultations were required before URS procedure. All patients underwent preoperative intravenous antibiotic prophylaxis. URS procedures were performed under general anaesthesia without using halothane and nitric oxide. URS procedures were realised using a 7.5 F (Olympus Inc., Japan) or a 9.5 F (Karl Storz Inc., Germany) semi-rigid ureteroscope under direct endoscopic vision without fluoroscopic guidance. Ureters were accessed using 0.038 inch guide wires and in 3 patients balloon dilation of the stenotic distal end of the ureter was needed before intraureteral access. The stones were fragmented using holmium-YAG laser (Auriga, Wavelight Laser Tecnologie AG, Germany). A forcep was used for extraction of stone fragments. Cases with oedema secondary to an impacted stone, with presence of a concomitant renal stone or with ureteral trauma caused by URS necessitated double J stent application. During the early postoperative period, meticulous obstetric care was offered to all patients to ensure maternal and foetal well-being.
RESULTS
The mean age of the patients and the mean gestational age were 25.4 (18-41) years and 24.8 (7-33) weeks, respectively. Patient characteristics are listed in Table 1 . Medical history of the patients revealed the existence of solitary kidney secondary to nephrectomy in 2, hypoplastich kidney in 1, and a past history of stone disease in 6 (31.5%). The symptoms were renal colic in 14 (73.6%) patients, fever in 2 (10.5%) patients and microscopic ema turia/ pyuria was observed in 9 (47.3%) patients. Eight (42.1%) patients had right and eleven (57.9%) had left side hydronephrosis. Four (21%) patients had positive urine cultures. The mean stone size determined by pre-operative ultrasound in 6 patients was 9. 2mm (6-13 mm). US detected grade I hydronephrosis in 2 (10.5%), grade II in 10 (52.9%) and grade III in 7 (36.8%) patients. Ureteric stones were found in the distal ureter in 8 (42.1%), middle in 5 (26.3%) and proximal in 6 (31.5%) patients. The stones of all patients were fragmented using holmium: YAG laser lithotriptor. Stone fragments of 9 patients were extracted using forceps, while those of other 10 patients were left to spontaneous passage. Intraureteral double-J stents were implanted in 11 (57.8%) patients because of procedural oedema by impacted stone, concomitant renal stone, and intraureteral trauma during URS. Double-J stents of 7 patients were extracted 2-4 weeks after the first procedure. Stents of 3 patients with concomitant renal stones smaller than 2 cm were extracted after successful shockwave lithıtripsy (SWL) performed during the postnatal period. Double-J stent of one patient migrated on the 1st postoperative day. In 3 patients, following the procedure, an open end 5 F external ureteral catheter was inserted as a transitory stent. The stent was removed within 24 hours after the procedure. Details of the procedure and outcomes are presented in Table 2 . No intraoperative urological and obstetric complication was observed. During postoperative controls preterm uterine contractions (n = 1), and urinary tract infection (n = 1) developed. The patient who suffered from preterm uterine contractions was treated with tocolysis, and the other case with appropriate antibiotics. All newborns were healthy and delivered at term.
DISCUSSION
Hydronephrosis induced by pregnancy is the most prevalent cause of urinary tract infection and can lead to flank pain imitating renal colic. Upper urinary tract dilation is seen in 90% of pregnant women in their third trimesters, and it may persist up to 12 weeks postpartum. Dependent on the position of the foetus, it is more prevalent on the right side (9) . During pregnancy, urolithiasis and episodes of renal colic can lead to the development of hydronephrosis and urinary stasis ensuing in pyelonephritis and urinary tract infection. These complications can eventually result in obstetric complications as spontaneous rupture, premature birth and the delivery of low birth weight new-borns (10). Fifty to eighty per cent of pregnant women suffering from symptomatic urolithiasis can pass their stones thanks to conservative treatment modalities including intravenous hydration and analgesia (1, 4) . In some patients more invasive treatment modalities may be required and in 20-30% of pregnant women with urolithiasis surgical treatment may be required (11) . Conventional treatment of obstructed ureter can be accomplished by placement of a percutaneous nephrostomy (PCN) tube or insertion of an ureteral stent. However, placement of a PCN tube and of a ureteral stent in the early stages of the pregnancy can be associated with some risks as incrustation, patient' s discomfort and urinary tract infection (12) (13) (14) . Because of physiological hydronephrosis developed during pregnancy, ureteral stents can migrate more frequently (15) . Recent advances in surgical technology have revolutionised the designs of semi-rigid and flexible ureteroscopes leading to increased use of URS in pregnant women. Miniaturisation of ureteroscopes, and advances in intracorporeal lithotripsy technology ensure successful intraureteral access and management of stones at any level of the urinary tract without any traumatic complication (16) . Since collecting system and ureter undergo physiological dilation in pregnancy, ureteroscopic procedures can be achieved without need for dilatation of the ureteral orifice (17) (18) (19) (22) . However, the impact of higher frequency vibrations on foetal organs has not been fully yet acknowledged and possible risks related to the hearing ability of the foetus have been advocated by some Authors (19) . These concerns have led to the development of devices such as holmium laser, pulsed-dye laser or pneumatic lithotriptors that focus their energy on a localised area with minimal energy dispersion. Pneumatic lithotriptors can be used only with a semi-rigid ureteroscope because of their rigid probes. On the other hand, pulseddye laser lithotriptor cannot fragment stones with hard composition (23) . As a result of continuous technological advances, a compact laser system was developed, which emits highly water-absorbable shock waves at 2140 nm wavelength. Holmium: YAG laser disperses its energy via a flexible fibre, which facilitates intracorporeal lithotripsy into collecting system. Holmium laser lithotriptor can be safely used if activated 0.5-1.0 mm away from the ureteral wall (24) . Holmium laser lithotriptor is advantageous over other lithotriptors in that it can be used with both semi-rigid and flexible ureteroscopes, and has the capacity to fragment all types of stones with varying compositions (23) . Other advantages of Holmium laser lithotriptors, can be enumerated including their ability to fragment the stones into relatively small particles when compared with other types of lithotriptors. These small stone particles can be easily eliminated from the collecting system without the need for stone basket or grasper for their extraction (25) . When compared with EHL or pneumatic lithotriptors, Holmium laser lithotriptors create weak shock waves, which decrease the probability of retropulsion of stones and/or stone particles (25, 26 (12) also reported placement of double-J ureteral stents in 12 of (63%) 19 pregnant patients who were relieved of obstructive ureteral stones using pneumatic lithotriptors under the guidance of ureterorenoscopy. We also inserted double-J ureteral stents in 11 (57.8 %) of 19 patients following URS procedures. Stents were placed with the aid of 9.5 F ureteroscopes under direct vision. However, in patients in whom we used 7.5 F ureteroscopes, firstly a guide wire was inserted and advanced through a ureteroscope under direct vision into the kidney, and then the position of the guide wire was confirmed by US. Double-J stents of 7 patients were removed within 2-4 weeks after the first procedure with the aid of a cystoscope under local anaesthesia. On the 1st postoperative day after the URS procedure double-J stent migrated in one patient who was monitored for occurrence of renal colic and development of pelvicalyceal dilation by periodic US examinations. Since renal colic and pelvicalyceal dilation did not occur, double-J stent was not re-implanted. Double-J stents of 3 patients were removed after they became stone-free following SWL in the postnatal period due to the presence of concomitant renal stone. No complication related to the implantation of double-J stents occurred. Complications related to URS procedure in pregnant women are not frequent. URS complication rates in pregnant and non-pregnant women are not different. In their meta-analysis consisting of 108 pregnant women who had undergone ureteroscopic stone management, Michelle et al. classified a total of 9 complications according to modified Clavien criteria (8) , and reported 2 level 1, 6 level 2, and 1 level 3 complications (28). In our series a total of 2 patients developed complications consisting in preterm uterine contractions (n = 1) which were managed with tocolysis and urinary tract infection (UTI) (n = 1) which was treated with appropriate antibiotics. According to Clavien classification, these complications were rated level 1 and 2, respectively.
CONCLUSION
In conservative treatment of pregnant patients with refractory symptomatic stones at any ureteral location which cannot pass spontaneously, semi-rigid-URS can be used safely for diagnostic and therapeutic purposes. Holmium: YAG laser lithotripter, which is the most effective intracorporeal lithotriptor for all kinds of stones at every location in the urinary tract with semi-rigid URS, can be used successfully and safely in pregnant women with acceptable maternal and foetal complication rates.
